Published: 10 June 2026
The English Chronicle Desk
The English Chronicle Online
A new form of advanced radiotherapy for prostate cancer could dramatically reduce treatment times, with patients potentially requiring just five sessions instead of the traditional 20, according to healthcare officials and medical researchers.
The approach uses highly targeted radiation technology to deliver precise doses directly to cancerous tissue while minimising exposure to surrounding healthy organs and structures.
Experts say the technique has the potential to improve patient convenience, reduce pressure on healthcare services and increase treatment capacity across cancer centres.
Prostate cancer is one of the most commonly diagnosed cancers among men, and radiotherapy remains a key treatment option for many patients following diagnosis.
Traditional treatment schedules often require patients to attend hospital over several weeks, creating logistical and financial challenges for some individuals and their families.
The newer treatment model aims to provide equivalent clinical outcomes in a significantly shorter timeframe by using more precise imaging and radiation delivery systems.
Cancer specialists say advances in technology have enabled doctors to safely administer higher doses during fewer appointments while maintaining treatment effectiveness.
Healthcare leaders believe the innovation could help reduce waiting times and improve access to radiotherapy services as demand for cancer treatment continues to grow.
Patient groups have welcomed developments that reduce the burden of treatment while maintaining high standards of care and clinical safety.
Researchers involved in the programme said ongoing monitoring will continue to assess long-term outcomes, side effects and overall patient experiences.
Medical professionals stressed that treatment plans will continue to be tailored to individual patients, with suitability determined by clinical assessments and cancer characteristics.
The development reflects broader efforts to modernise cancer care through technological innovation, earlier diagnosis and more personalised treatment strategies.



























































































